CalciMedica, Inc.
CALC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $14 |
| Gross Profit | $0 | $0 | $0 | -$14 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,851 | $4,052 | $4,224 | $3,831 |
| G&A Expenses | $0 | $2,569 | $2,273 | $0 |
| SG&A Expenses | $1,767 | $2,569 | $2,273 | $2,327 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,618 | $6,621 | $6,497 | $6,158 |
| Operating Income | -$5,618 | -$6,621 | -$6,497 | -$6,172 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,186 | $665 | $1,455 | $1,914 |
| Pre-Tax Income | -$7,804 | -$5,956 | -$5,042 | -$4,258 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,804 | -$5,956 | -$5,042 | -$4,258 |
| % Margin | – | – | – | – |
| EPS | -0.52 | -0.4 | -0.36 | -0.33 |
| % Growth | -30% | -11.1% | -9.1% | – |
| EPS Diluted | -0.52 | -0.4 | -0.36 | -0.33 |
| Weighted Avg Shares Out | 14,995 | 14,995 | 14,122 | 12,761 |
| Weighted Avg Shares Out Dil | 14,995 | 14,995 | 14,122 | 12,761 |
| Supplemental Information | – | – | – | – |
| Interest Income | $140 | $220 | $202 | $0 |
| Interest Expense | $326 | $324 | $447 | $0 |
| Depreciation & Amortization | $0 | $14 | $15 | $14 |
| EBITDA | -$7,478 | -$5,618 | -$4,580 | -$4,244 |
| % Margin | – | – | – | – |